PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,175,000 | -68.5% | 176,202 | -17.9% | 0.01% | -69.0% |
| Q4 2015 | $16,434,000 | -7.4% | 214,746 | -8.8% | 0.03% | -12.1% |
| Q3 2015 | $17,749,000 | +14.8% | 235,533 | +77.9% | 0.03% | +32.0% |
| Q2 2015 | $15,459,000 | +993.3% | 132,412 | +2109.4% | 0.02% | +733.3% |
| Q1 2015 | $1,414,000 | +33.9% | 5,993 | +7.6% | 0.00% | +50.0% |
| Q4 2014 | $1,056,000 | +13.3% | 5,570 | +42.6% | 0.00% | 0.0% |
| Q3 2014 | $932,000 | +47.5% | 3,906 | +34.7% | 0.00% | +100.0% |
| Q2 2014 | $632,000 | +857.6% | 2,900 | +227.7% | 0.00% | – |
| Q1 2014 | $66,000 | -74.4% | 885 | -81.6% | 0.00% | – |
| Q3 2013 | $258,000 | +24.0% | 4,816 | +2.5% | 0.00% | – |
| Q2 2013 | $208,000 | – | 4,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |